GO:0008108 UDP-glucose:hexose-1-phosphate uridylyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008108 describes the enzymatic activity that interconverts alpha-D-galactose 1-phosphate and UDP-D-glucose into alpha-D-glucose 1-phosphate and UDP-D-galactose, a central step of the Leloir pathway.
• The reaction is reversible and enables cells to channel galactose into glucose metabolism while regenerating UDP-glucose/UDP-galactose pools.
• In Bifidobacterium bifidum, two distinct uridylyltransferases (GalT1 and GalT2) contribute to Leloir pathway flux, illustrating evolutionary diversification of this activity.
• The same enzymatic activity participates in the lacto-N-biose I/galacto-N-biose metabolic pathway of Bifidobacterium longum, linking it to human milk oligosaccharide utilization.
• Loss or impairment of this activity causes galactose accumulation and is associated with classic galactosemia in humans, making it a clinically important enzyme target.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow precise dissection of GO:0008108 in microbial and mammalian systems.
Description
UDP-glucose:hexose-1-phosphate uridylyltransferase activity (GO:0008108) is a molecular function that catalyzes the reversible transfer of a uridylyl group between UDP-glucose and alpha-D-galactose 1-phosphate, yielding UDP-galactose and alpha-D-glucose 1-phosphate. This activity is a defining component of the Leloir pathway, the main route by which galactose is converted into glucose derivatives for energy production and glycosylation. Because the reaction sits at the intersection of nucleotide-sugar metabolism and hexose catabolism, it is essential for maintaining cellular UDP-glucose and UDP-galactose pools that feed into glycoconjugate biosynthesis. In Bifidobacterium bifidum, two uridylyltransferases with this activity were identified and shown to be differentially important for Leloir pathway function, demonstrating that the same GO term can be carried out by multiple, non-redundant enzymes within one organism. In Bifidobacterium longum, a related uridylyltransferase participates in the lacto-N-biose I/galacto-N-biose pathway, connecting GO:0008108 to the metabolism of human milk oligosaccharides and host-microbe interactions. For researchers, GO:0008108 is therefore both a mechanistic node in sugar metabolism and a potential target for understanding metabolic disorders, microbial niche adaptation, and glycan-dependent host-microbe crosstalk.
UDP-glucose:hexose-1-phosphate uridylyltransferase activity At A Glance
| GO ID | GO:0008108 |
|---|---|
| GO term | UDP-glucose:hexose-1-phosphate uridylyltransferase activity |
| Ontology | molecular_function |
| Synonym | Gal-1-P uridylyltransferase activity; galactose-1-phosphate uridylyltransferase activity; hexose 1-phosphate uridyltransferase activity; hexose-1-phosphate uridylyltransferase activity; UDP-glucose:alpha-D-galactose-1-phosphate uridylyltransferase activity; UDPglucose:alpha-D-galactose-1-phosphate uridylyltransferase activity; UDP-glucose-hexose-1-phosphate uridylyltransferase activity; UDPglucose-hexose-1-phosphate uridylyltransferase activity; uridyl transferase activity; uridyltransferase activity; uridylyl removing enzyme activity |
| Major function | Reversible uridylyl transfer between UDP-glucose and alpha-D-galactose 1-phosphate, producing UDP-galactose and alpha-D-glucose 1-phosphate |
| Reaction | alpha-D-galactose 1-phosphate + UDP-D-glucose = alpha-D-glucose 1-phosphate + UDP-D-galactose |
| Pathway context | Leloir pathway for galactose metabolism; lacto-N-biose I/galacto-N-biose pathway in bifidobacteria |
| Representative enzymes | GalT-type uridylyltransferases in bacteria and eukaryotes; bifidobacterial GalT1 and GalT2 |
| Disease relevance | Classic galactosemia in humans when the activity is deficient |
What Is GO:0008108?
GO:0008108 is defined by QuickGO as the catalysis of the reaction: alpha-D-galactose 1-phosphate + UDP-D-glucose = alpha-D-glucose 1-phosphate + UDP-D-galactose. In other words, the enzyme transfers a uridylyl group from UDP-glucose to galactose 1-phosphate, producing UDP-galactose and glucose 1-phosphate. The activity is reversible and belongs to the molecular_function ontology. Common synonyms include galactose-1-phosphate uridylyltransferase activity, hexose-1-phosphate uridylyltransferase activity, and uridyl transferase activity.
Why Is UDP-glucose:hexose-1-phosphate uridylyltransferase activity Important in Cell Biology?
GO:0008108 is important because it controls the interconversion of galactose 1-phosphate and glucose 1-phosphate, a step that determines whether galactose can be efficiently catabolized or must be diverted into alternative, potentially toxic routes. In microorganisms such as Bifidobacterium bifidum, the presence of multiple uridylyltransferases with this activity shapes carbon source utilization and competitive fitness in the gut. In Bifidobacterium longum, the same activity is embedded in the lacto-N-biose I/galacto-N-biose pathway, which is central to the degradation of human milk oligosaccharides and to infant gut colonization. In humans, inherited deficiency of galactose-1-phosphate uridylyltransferase causes classic galactosemia, a disorder characterized by galactose intolerance and multi-organ complications, underscoring the clinical importance of this GO term. Because the reaction is reversible, it also contributes to the regeneration of UDP-glucose and UDP-galactose pools required for glycosylation, making it relevant to glycobiology, metabolic engineering, and host-microbe interaction studies.
• Defines a core step of the Leloir pathway for galactose metabolism.
• Maintains cellular pools of UDP-glucose and UDP-galactose for glycosylation reactions.
• Supports lacto-N-biose I/galacto-N-biose metabolism in Bifidobacterium longum.
• Contributes to human milk oligosaccharide utilization by gut bifidobacteria.
• Loss of activity is linked to classic galactosemia and galactose toxicity in humans.
• Multiple uridylyltransferases can carry out this activity in one organism, enabling metabolic flexibility.
• Provides a target for metabolic engineering of galactose utilization in microbes.
• Serves as a model for studying reversible uridylyl transfer and nucleotide-sugar interconversion.
• Connects sugar metabolism to host-microbe interactions in the infant gut.
• Enables CRISPR-based dissection of gene function in galactose metabolic pathways.
Molecular Mechanism of UDP-glucose:hexose-1-phosphate uridylyltransferase activity
Substrate recognition and binding
In simple terms: The enzyme grabs two sugar molecules that carry phosphate or UDP groups.
The enzyme binds alpha-D-galactose 1-phosphate and UDP-D-glucose as its substrates, positioning them for uridylyl transfer. In Bifidobacterium bifidum, two distinct uridylyltransferases (GalT1 and GalT2) were identified that can carry out this reaction, indicating that substrate recognition is conserved but the enzymes are not redundant. The reaction is reversible, so the same active site can also bind alpha-D-glucose 1-phosphate and UDP-D-galactose as substrates for the reverse direction.
Uridylyl transfer chemistry
In simple terms: A uridylyl group is swapped between two sugar phosphates.
During catalysis, the uridylyl group from UDP-glucose is transferred to alpha-D-galactose 1-phosphate, forming UDP-galactose and alpha-D-glucose 1-phosphate. This is a group-transfer reaction that does not require a separate energy source because the phosphoanhydride bond of UDP-glucose provides the driving force. The equilibrium of the reaction allows the enzyme to operate in either direction depending on the relative concentrations of substrates and products.
Role in the Leloir pathway
In simple terms: This step is one of the main steps that lets cells use galactose.
In the Leloir pathway, galactose is first phosphorylated and then converted by this uridylyltransferase activity into glucose 1-phosphate, which can enter glycolysis or be used for glycosylation. In Bifidobacterium bifidum, the Leloir pathway was unraveled and the significance of the uridylyltransferases was demonstrated, showing that this activity is essential for galactose utilization in that organism. The pathway also regenerates UDP-glucose from UDP-galactose through subsequent reactions, maintaining nucleotide-sugar homeostasis.
Participation in the lacto-N-biose I/galacto-N-biose pathway
In simple terms: The same activity also helps break down special sugars found in human milk.
In Bifidobacterium longum, a uridylyltransferase activity is part of the complete lacto-N-biose I/galacto-N-biose metabolic pathway, which is used to metabolize human milk oligosaccharides. This links GO:0008108 to the catabolism of galactose-containing glycans and to the ecological success of bifidobacteria in the infant gut. The pathway requires coordinated action of kinases, epimerases, and uridylyltransferases, with this activity providing the interconversion between galactose 1-phosphate and glucose 1-phosphate.
Regulation and reversibility
In simple terms: The enzyme can work in both directions depending on what the cell needs.
Because the reaction is reversible, the direction of flux through GO:0008108 depends on substrate availability and the metabolic state of the cell. In Bifidobacterium bifidum, the presence of two uridylyltransferases suggests that their expression or activity may be differentially regulated to balance Leloir pathway flux. The activity is also influenced by the availability of galactose and glucose in the environment, which determines whether the enzyme operates in the catabolic or biosynthetic direction.
Key Genes Involved in GO:0008108 UDP-glucose:hexose-1-phosphate uridylyltransferase activity
The following genes and proteins are directly associated with UDP-glucose:hexose-1-phosphate uridylyltransferase activity (GO:0008108) or with the pathways in which this activity functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| galT (Bifidobacterium bifidum) | Encodes a uridylyltransferase that catalyzes the Leloir pathway reaction | Used to study galactose utilization and pathway redundancy |
| galT1 (Bifidobacterium bifidum) | One of two uridylyltransferases with this activity | Demonstrates non-redundant roles in Leloir pathway flux |
| galT2 (Bifidobacterium bifidum) | Second uridylyltransferase with this activity | Shows differential importance for galactose metabolism |
| galK | Galactokinase that phosphorylates galactose to galactose 1-phosphate | Provides substrate for GO:0008108 |
| galE | UDP-glucose 4-epimerase that interconverts UDP-glucose and UDP-galactose | Works with GO:0008108 to maintain nucleotide-sugar pools |
| galM | Galactose mutarotase that converts beta-D-galactose to alpha-D-galactose | Supplies the correct substrate anomer for the pathway |
| galT (Bifidobacterium longum) | Uridylyltransferase in the lacto-N-biose I/galacto-N-biose pathway | Links GO:0008108 to human milk oligosaccharide metabolism |
| lnbP | Lacto-N-biose I phosphorylase | Generates galactose 1-phosphate for the uridylyltransferase reaction |
| lnbK | N-acetylhexosamine 1-kinase | Phosphorylates N-acetylhexosamines in the LNB/GNB pathway |
| gnbP | Galacto-N-biose phosphorylase | Produces galactose 1-phosphate in the GNB pathway |
| GALE (human) | UDP-galactose 4-epimerase | Maintains UDP-galactose/UDP-glucose balance with GO:0008108 |
| GALT (human) | Galactose-1-phosphate uridylyltransferase | Deficiency causes classic galactosemia |
| GALK1 (human) | Galactokinase 1 | Phosphorylates galactose upstream of GO:0008108 |
| GALK2 (human) | Galactokinase 2 | Alternative galactose phosphorylation enzyme |
| PGM1 (human) | Phosphoglucomutase 1 | Converts glucose 1-phosphate to glucose 6-phosphate downstream of GO:0008108 |
| UGP2 (human) | UDP-glucose pyrophosphorylase 2 | Produces UDP-glucose, a substrate for GO:0008108 |
| Bifidobacterium bifidum galT operon | Gene cluster for Leloir pathway enzymes | Target for metabolic engineering of galactose utilization |
| Bifidobacterium longum LNB/GNB cluster | Gene cluster for lacto-N-biose I/galacto-N-biose metabolism | Model for host-microbe glycan interactions |
How Is UDP-glucose:hexose-1-phosphate uridylyltransferase activity Regulated?
The activity of UDP-glucose:hexose-1-phosphate uridylyltransferase is regulated at multiple levels. In Bifidobacterium bifidum, the presence of two distinct uridylyltransferases (GalT1 and GalT2) suggests that their expression is differentially controlled to match metabolic demand for galactose utilization. Substrate availability, particularly the intracellular concentrations of alpha-D-galactose 1-phosphate and UDP-glucose, directly influences the direction and rate of the reversible reaction. In Bifidobacterium longum, the lacto-N-biose I/galacto-N-biose pathway, which includes a uridylyltransferase step, is induced by specific glycans found in human milk, indicating that this activity is regulated by nutritional cues. Additionally, the overall flux through the Leloir pathway is coordinated with galactokinase (galK) and UDP-glucose 4-epimerase (galE) activities to prevent accumulation of toxic intermediates such as galactose 1-phosphate.
UDP-glucose:hexose-1-phosphate uridylyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GALT (human) | Classic galactosemia | CRISPR knockout of GALT in HepG2 cells followed by galactose challenge |
| galT1 (Bifidobacterium bifidum) | Galactose utilization defect | Knockout in B. bifidum and growth assay on galactose |
| galT2 (Bifidobacterium bifidum) | Leloir pathway redundancy | Double knockout with galT1 to assess synthetic lethality |
| galT (Bifidobacterium longum) | Human milk oligosaccharide metabolism | Knockout in B. longum and growth on LNB/GNB |
| lnbK (Bifidobacterium longum) | LNB/GNB pathway deficiency | Point mutation in kinase domain to block substrate supply |
Classic galactosemia
Deficiency of galactose-1-phosphate uridylyltransferase activity (GO:0008108) in humans causes classic galactosemia, an inherited metabolic disorder characterized by the inability to metabolize galactose. The accumulation of galactose 1-phosphate and other galactose metabolites leads to multi-organ complications, including liver dysfunction, cataracts, and neurological impairments. Research on bifidobacterial uridylyltransferases provides comparative insights into the structure-function relationships of this enzyme family and may inform therapeutic strategies.
Galactose metabolism disorders and metabolic stress
Beyond classic galactosemia, impaired GO:0008108 activity can contribute to broader metabolic stress because galactose 1-phosphate is toxic when it accumulates. Cells with reduced uridylyltransferase activity may shift galactose into alternative pathways, producing abnormal sugar alcohols and affecting osmotic balance. Understanding how different organisms, such as Bifidobacterium bifidum, manage this activity through multiple enzymes may reveal compensatory mechanisms relevant to human disease.
Host-microbe interactions and infant gut health
In Bifidobacterium longum, the uridylyltransferase activity within the lacto-N-biose I/galacto-N-biose pathway is important for utilizing human milk oligosaccharides, which are abundant in breast milk. Disruption of this pathway could affect the ability of beneficial bifidobacteria to colonize the infant gut, potentially influencing immune development and susceptibility to pathogens. Thus, GO:0008108 is indirectly linked to host-microbe interactions and infant health.
From UDP-glucose:hexose-1-phosphate uridylyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GO:0008108 activity cause galactose sensitivity? | CRISPR knockout of GALT in human cell lines |
| Are GalT1 and GalT2 functionally redundant in B. bifidum? | Single and double CRISPR knockouts in B. bifidum |
| What is the catalytic efficiency of mutant uridylyltransferases? | Point mutations in the active site followed by enzyme kinetics |
| Can a tagged uridylyltransferase be used to study localization? | Knock-in of FLAG or GFP tag at the endogenous locus |
| Does overexpression of galT improve galactose utilization? | Overexpression of galT in B. bifidum or E. coli |
| Is the LNB/GNB pathway dependent on uridylyltransferase activity? | Knockout of galT in B. longum and growth on LNB |
How to Study the UDP-glucose:hexose-1-phosphate uridylyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Coupled enzyme assay | Uridylyltransferase activity | Confirming GO:0008108 in recombinant enzymes |
| CRISPR knockout | Gene function | Testing galactose utilization in B. bifidum |
| RNA-seq | Gene expression changes | Identifying carbon source regulation |
| Proteomics | Protein abundance | Validating enzyme levels in pathway mutants |
| Site-directed mutagenesis | Catalytic residue importance | Mapping active site of uridylyltransferases |
| Growth phenotyping | Fitness on specific sugars | Assessing LNB/GNB pathway function |
| X-ray crystallography | Three-dimensional structure | Understanding substrate binding |
| Complementation assay | Rescue of knockout phenotype | Confirming gene-phenotype linkage |
Enzymatic activity assays
Direct measurement of UDP-glucose:hexose-1-phosphate uridylyltransferase activity is typically performed using coupled spectrophotometric or chromatographic assays that monitor the formation of UDP-galactose or glucose 1-phosphate. These assays are essential for confirming that a candidate gene encodes an enzyme with GO:0008108 activity and for comparing the kinetic properties of different isoforms such as GalT1 and GalT2.
Genetic knockout and complementation
CRISPR-based knockout of candidate genes followed by growth phenotyping on galactose or human milk oligosaccharides provides a robust way to link a gene to GO:0008108 function. Complementation with wild-type or mutant alleles can then confirm that the observed phenotype is due to loss of the uridylyltransferase activity.
Transcriptomics and proteomics
RNA-seq and proteomics can reveal how expression of uridylyltransferase genes responds to different carbon sources, such as galactose or lacto-N-biose. These methods help identify regulatory networks that control GO:0008108 activity in response to environmental cues.
Structural and mutational analysis
X-ray crystallography and site-directed mutagenesis can identify active-site residues required for uridylyl transfer, providing mechanistic insight into GO:0008108. Such studies are particularly useful for comparing the two bifidobacterial uridylyltransferases and understanding their differential roles.
How CRISPR Can Be Used to Study GO:0008108 UDP-glucose:hexose-1-phosphate uridylyltransferase activity
Knockout
CRISPR knockout of genes encoding uridylyltransferases, such as galT1 and galT2 in Bifidobacterium bifidum, allows researchers to determine whether loss of GO:0008108 activity impairs growth on galactose. In human cells, knockout of GALT can model classic galactosemia and reveal downstream metabolic consequences. Knockout studies in Bifidobacterium longum can test the requirement for the uridylyltransferase step in the lacto-N-biose I/galacto-N-biose pathway.
Point Mutation
Point mutations introduced into the active site of uridylyltransferases can dissect the catalytic mechanism of GO:0008108, for example by altering residues involved in uridylyl transfer. Such mutants can be expressed in a knockout background to test whether specific amino acids are essential for enzyme activity. This approach is valuable for distinguishing between catalytic and structural roles of conserved residues.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins at the endogenous locus enables visualization and immunoprecipitation of uridylyltransferases without overexpression artifacts. Tagged knock-in lines can be used to study protein localization, complex formation, and post-translational modifications under native regulatory control. This is particularly useful for comparing the expression and localization of GalT1 and GalT2 in B. bifidum.
Overexpression
Overexpression of uridylyltransferase genes can be used to test whether increased GO:0008108 activity enhances galactose utilization or alters metabolic flux. In Bifidobacterium bifidum, overexpression of galT1 or galT2 may reveal which enzyme is rate-limiting under specific conditions. Overexpression in heterologous hosts such as E. coli can facilitate enzyme purification and biochemical characterization.
How EDITGENE Supports UDP-glucose:hexose-1-phosphate uridylyltransferase activity Research
Researchers studying UDP-glucose:hexose-1-phosphate uridylyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in galactose metabolism, glycan utilization, or disease-associated metabolic dysfunction. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that enable such causal inferences.
Contact EDITGENE today to design your custom CRISPR model for UDP-glucose:hexose-1-phosphate uridylyltransferase activity research.
Frequently Asked Questions About UDP-glucose:hexose-1-phosphate uridylyltransferase activity
What is UDP-glucose:hexose-1-phosphate uridylyltransferase activity?
It is the enzymatic activity defined by GO:0008108 that catalyzes the reversible conversion of alpha-D-galactose 1-phosphate and UDP-D-glucose to alpha-D-glucose 1-phosphate and UDP-D-galactose.
What genes are involved in UDP-glucose:hexose-1-phosphate uridylyltransferase activity?
Key genes include galT1 and galT2 in Bifidobacterium bifidum, galT in Bifidobacterium longum, and GALT in humans.
What is the role of GO:0008108 in the Leloir pathway?
GO:0008108 catalyzes a central step in the Leloir pathway, allowing galactose to be converted into glucose 1-phosphate for energy production and glycosylation.
How is UDP-glucose:hexose-1-phosphate uridylyltransferase activity measured?
It is typically measured using coupled enzyme assays that detect the formation of UDP-galactose or glucose 1-phosphate, often with recombinant enzymes.
What diseases are associated with defects in this activity?
Deficiency of galactose-1-phosphate uridylyltransferase causes classic galactosemia, a metabolic disorder with multi-organ complications.
Can CRISPR be used to study GO:0008108?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the function of genes encoding this activity.
Which organisms have multiple uridylyltransferases?
Bifidobacterium bifidum has two distinct uridylyltransferases, GalT1 and GalT2, that both carry out this activity.
What is the connection between GO:0008108 and human milk oligosaccharides?
In Bifidobacterium longum, a uridylyltransferase participates in the lacto-N-biose I/galacto-N-biose pathway, which metabolizes human milk oligosaccharides.
Is the reaction catalyzed by GO:0008108 reversible?
Yes, the reaction is reversible, allowing the enzyme to interconvert UDP-glucose and UDP-galactose depending on metabolic needs.
How can I create a knockout model for a uridylyltransferase gene?
EDITGENE provides custom CRISPR knockout services for uridylyltransferase genes in human and microbial cell lines.
Conclusion
UDP-glucose:hexose-1-phosphate uridylyltransferase activity (GO:0008108) is a fundamental molecular function that bridges galactose metabolism and nucleotide-sugar homeostasis. Its presence in diverse organisms, from bifidobacteria to humans, underscores its evolutionary importance and its relevance to health and disease. By leveraging CRISPR-based models and advanced bioinformatics, researchers can now dissect the precise roles of this activity in metabolic pathways, host-microbe interactions, and inherited disorders.
References
- 1. De Bruyn F et al.. 2013. Unraveling the Leloir pathway of Bifidobacterium bifidum: significance of the uridylyltransferases.. Appl Environ Microbiol 79(22):7028-35 PMID: 24014529
- 2. Nishimoto M et al.. 2007. Identification of N-acetylhexosamine 1-kinase in the complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum.. Appl Environ Microbiol 73(20):6444-9 PMID: 17720833
